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Schistosome infections are characterized by promi-
nent T cell hyporesponsiveness during the chronic stage
of infection. We found that schistosome-specific phos-
phatidylserine (PS) activated TLR2 and affected den-
dritic cells such that mature dendritic cells gained the
ability to induce the development of IL-10-producing
regulatory T cells. Using mass spectrometry, schistoso-
mal lysophosphatidylserine (lyso-PS) was identified as
the TLR2-activating molecule. This activity appears to
be a unique property of schistosomal lyso-PS, contain-
ing specific acyl chains, because neither a synthetic
lyso-PS (16:0) nor PS isolated from the mammalian host
activates TLR2. Taken together, these findings provide
evidence for a novel host-parasite interaction that may
be central to long term survival of the parasite and
limited host pathology with implications beyond
parasitology.
Schistosomes are trematodes that cause schistosomiasis, a
chronic blood-vascular disease that is associated with a Th2
response (1), but at chronic stages of infection also with en-
hanced IL-10 production and suppressed T cell proliferation to
parasite antigens (2). The anti-inflammatory responses induced
by helminths seem to enable parasite survival within the host
with limited inflammatory responses that might otherwise be
destructive to the host tissues. This controlled immune response,
central to chronic helminth infections, may arise from signals
received from the pathogen, as the chronic presence of meta-
bolically active helminths is mirrored by persistent challenge of
the immune system with an array of molecules associated with
parasite metabolism, reproduction, and attrition.
Recognition of an invading microorganism by cells of the
immune system involves pathogen-associated molecular pat-
terns that bind specific germline-encoded receptors on the host
cells. Toll-like receptors (TLRs)1 with extracellular leucine-rich
domains and intracellular IL-1 receptor homology domain are
important members of such germline-encoded receptors and
actively participate in the stimulation of innate immune re-
sponses. To date, ten TLR homologs have been found in hu-
mans, and ligands have been identified for several TLRs, most
of which are of bacterial origin (3–5).
Instructions for development of specific immune responses
are largely mediated by dendritic cells, which are present in
peripheral tissues such as sentinel dendritic cells, and upon
activation migrate to the draining lymph nodes to activate
naive T cells, not only by presenting antigen but also by pro-
viding signals that determine polarization of T cell develop-
ment toward a Th1 (6, 7), Th2 (6), or T regulatory phenotype
(8). In this way, dendritic cells can play a central role in
providing information on the nature of the invading pathogen
by integrating signals received and conveying them to T cells
by expressing a variety of factors that will determine differen-
tiation of T cells into polarized subsets (9).
Dendritic cells express several TLRs, depending on their
developmental stage and lineage (10, 11). Recently, several
studies have shown that bacterial products induce maturation
of dendritic cells via TLRs (12, 13). Furthermore, activation of
TLR2 or TLR4 in immature dendritic cells can lead to expres-
sion of distinct cytokine profiles (14). However, it is still unclear
to what extent activation of TLRs on dendritic cells influences
the T cell phenotype associated with infectious diseases.
Several bacterial products considered as pathogen-associ-
ated molecular patterns have been shown to contain lipid moi-
eties that are essential for activation of TLRs (15–17). Indeed,
growing interest in lipids and their receptor biology has gen-
erated insights into interaction of this class of molecules with
the immune system and into the role they may play in immu-
nopathologies (18). A variety of lipid moieties can bind to spe-
cific receptors on the cells of the innate immune system and
thereby play a role in immune regulation. For example, the
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binding of lysophosphatidylcholine to its receptor appears to
have important immunomodulatory function because the dele-
tion of the murine gene encoding the lysophosphatidylcho-
line-R (that is constitutively expressed in immune cells) re-
sulted in adult-onset autoimmune disease similar to human
systemic lupus erythematosus (19), -galactosylceramide pre-
vents onset or recurrence of autoimmune diabetes when pre-
sented in the context of the surface molecule CD1d (20), and the
platelet activating factor receptor induces the production of
pro- or anti-inflammatory mediators when activated by PAF or
oxidized phosphatidylcholine (21).
Here, we have concentrated on the role of schistosome lipids
in interaction with the innate immune system. We stimulated
dendritic cells with lipid classes derived from Schistosoma
mansoni eggs and adult worms and found that the fraction
containing phosphatidylserine (PS) polarized the maturation of
dendritic cells, resulting in Th2 skewing and the development
of T regulatory cells. The activation of TLR2 on dendritic cells
by PS is essential for induction of development of IL-10-pro-
ducing regulatory T cells. Using HPLC and tandem mass spec-
trometry, a unique schistosomal lysophosphatidylserine (lyso-
PS) was identified as the TLR2-activating molecule. Thus,
specific lyso-PS species from schistosomes act on dendritic cells
via TLR2 to modify their T cell-stimulating property in such
manner that regulatory T cells are induced.
EXPERIMENTAL PROCEDURES
Lipid Isolation—Lipids were isolated from S. mansoni adult worms
and eggs and from the liver of a non-infected hamster and were frac-
tionated using a TEAE-cellulose column as detailed before (22). Briefly,
S. mansoni adult worms were collected by perfusion of golden hamsters
45–48 days after infection. S. mansoni eggs were isolated from livers of
infected hamsters after treatment of the liver homogenate with trypsin.
Total lipids were isolated according to the method described by Bligh
and Dyer (23) and were separated into different classes using TEAE-
cellulose column chromatography as described by Rouser et al. (24). The
fractions containing PS were used for stimulation of dendritic cells and
HEK 293 cells. Synthetic lyso-PS (16:0) was purchased from Sigma.
Peripheral Blood Mononulcear Cell Isolation and Dendritic Cell Gen-
eration and Culture—Peripheral blood mononuclear cells were isolated
from venous blood of healthy volunteers by density centrifugation on
Ficoll. For peripheral blood mononuclear cell stimulation, cells were
seeded in 96-well flat-bottom plates at 1  106 cells/well in RPMI
medium as detailed before (25) in the presence of 5% FCS (Greiner) and
were stimulated with 100 ng/ml lipopolysaccharide (Sigma) or 10 g/ml
schistosomal lipids that were dissolved by water bath sonication in
RPMI containing 0.2% Me2SO.
For generation of dendritic cells, monocytes were isolated from pe-
ripheral blood mononuclear cells using a Percoll gradient as described
previously (6) and were cultured in RPMI medium supplemented with
10% FCS, human rGM-CSF (500 units/ml, specific activity 1.11  107
units/mg, a gift from Schering-Plough, Uden, The Netherlands) and
human rIL-4 (250 units/ml) (R&D Systems). At day 3, the culture
medium including the supplements was refreshed. At day 6,
CD1aCD14 immature dendritic cells were matured with maturation
factors (MF) (either LPS (100 ng/ml) or a combination of IL-1 (10
ng/ml) (Strathmann Biotechnology, Hannover, Germany) and tumor
necrosis factor  (50 ng/ml) (Strathman biotech) in the presence of
IFN- (103 units/ml), which induces the development of dendritic cells
that stimulate the polarization of naive T cells into Th1 (6); PGE2 (10
M), which induces the development of dendritic cells that stimulate the
polarization of naive T cells into Th2 (6); schistosome water-soluble egg
antigen (SEA) (100 g/ml), a parasite extract that induces the develop-
ment of dendritic cells that stimulate the polarization of naive T cells
into Th2 (6); or phosphatidylserine isolated from schistosome eggs or
adult worms (10 g/ml). No differences in the level of maturation of
dendritic cells exposed to the various compounds were found, as de-
tected by CD83, CD80, CD86, and HLA-DR expression (data not
shown), and therefore differential maturation could not play a role in
the polarizing effects observed. In blocking experiments, 10 g/ml of the
anti-TLR2 antibody TL2.1 (26) or a mouse IgG2 control antibody (CLB,
Amsterdam, The Netherlands) was added during dendritic cell matu-
ration. After 48 h, mature CD1a CD83 dendritic cells were obtained.
To measure cytokine production, 2  104 dendritic cells were co-cul-
tured with 2  104 CD40L-expressing mouse fibroblasts (J558 cells; a
kind gift from Dr. P. Lane, University of Birmingham, Birmingham,
UK). Levels of IL12p70 were determined in 24-h supernatants by
ELISA using monoclonal antibodies 20C2 (BD Biosciences) and bioti-
nylated mouse-anti-hu IL-12 C8.6 (BD Biosciences) as coating and
detection antibodies, respectively. Levels of IL-8 were determined using
a commercial ELISA kit (CLB, Amsterdam, The Netherlands) following
the manufacturer’s recommendations.
Determination of Naive Th Cell Polarization by Dendritic Cells—
Highly purified CD4CD45RACD45RO naive Th cells (98% as as-
sessed by flow cytometry) were purified from peripheral blood mononu-
clear cells using a human CD4/CD45RO column kit (R & D Systems).
2  104 naive Th cells were co-cultured with 5  103 mature dendritic
cells in the presence of superantigen Staphylococcus aureus enterotoxin
B (Sigma) at a final concentration of 100 pg/ml in 96-well flat-bottom
culture plates (Costar). At day 5, rhuIL-2 (10 units/ml, Cetus Corp.,
Emeryville, CA) was added and the cultures were expanded. On day 12,
the quiescent Th cells were restimulated with immobilized CD3 mAb
(CLB-T3/3, CLB, Amsterdam, The Netherlands) and soluble CD28 mAb
(CLB-CD28/1, CLB), and IL-10 was measured in 24-h supernatants
using a commercial kit (CLB) following the manufacturer’s recommen-
dations. To measure the frequency of IL-4- and IFN--producing cells,
Th cells were restimulated with PMA (Sigma) and ionomycin (Sigma) in
the presence of brefeldinA (Sigma) for 6 h. To detect intracellular
production of IL-4 and IFN-, cells were stained using anti-hu-IL-4-PE
(BD Biosciences) and anti-hu-IFN--FITC (BD Biosciences).
To assess regulatory capacity, the effect of T cells (grown in the
presence of dendritic cells that were matured with MF and during
maturation exposed to IFN-, PGE2, SEA, PS from eggs or PS from
worms) on proliferation of autologous Th cells was measured. T cells
grown in the presence of unpolarized dendritic cells (matured with MF)
were used as target cells for regulation. Effector T cells (5  104
cells/well) were co-cultured with target cells (5  104 cells/well) in the
presence of unpolarized mature dendritic cells (MF dendritic cells) (5 
103 cells/well). Cultures were done in triplicates. [3H]Thymidine was
added after 3 days of culture, and incorporation was measured after a
16-h pulse. The background proliferation of effector T cells (i.e. T-
effector  dendritic cells) was subtracted from the proliferation when
target cells were added (i.e. T-effector  dendritic cells  T-target).
Stimulation of Mouse Peritoneal Macrophages—Wild-type and TLR2
knockout mice (27, 28) were inoculated intraperitoneally with 2.5 ml of
3% thioglycolate solution. Peritoneal exudate cells were harvested with
cold RPMI 1640 medium containing 10% FCS and 10 g/ml ciprofloxa-
cin (gift from Miles Pharmaceuticals, West Haven, CT) 72 h post-
inoculation. The cells were washed and seeded at a density of 0.5  106
cells/well in 96-well flat-bottom plates. After 24 h, non-adherent cells
were removed by washing, and the adherent cells were stimulated with
repurified LPS (100 pg/ml) from Escherichia coli K 235 (gift from S.
Vogel, Uniformed Services University of the Health Sciences, Bethesda,
MD), heat-killed Listeria monocytogenes (HKLM) (106 cells/ml) (29),
and schistosomal egg and adult worm PS (10 g/ml). Tumor necrosis
factor  production was measured after 20 h using a commercial DuoSet
ELISA kit (R & D Systems).
Transfection of HEK 293 Cells—HEK 293 cells were cultured in
Dulbecco’s modified Eagle’s medium (BioWhittaker) supplemented with
10% FCS (Hyclone) and 10 g/ml ciprofloxacin. The cells were tran-
siently transfected at a density of 0.2  106 cells/well in 12-well plates
using PolyFect transfection reagent (Qiagen) with 0.5 g/transfection
TLR-expression plasmid and 0.5 g/transfection pELAM-luc, a reporter
construct that transcribes firefly luciferase from an NF-B-dependent
promoter, as described previously (30).
FLAG-tagged human TLR1 and TLR2 were provided by Tularic (San
Francisco, CA), FLAG-tagged TLR3 was PCR-cloned from a cDNA
(DNAX, Palo Alto, CA) into pFLAG-CMV1. Non-tagged human TLR4
(hTOLL) in pcDNA3 was a gift from C. Janeway and R. Medzhitov (Yale
University, New Haven, CT) and was co-transfected with human MD-2
(0.25 g DNA/transfection of TLR4 and MD-2), a gift from K. Miyake
(University of Tokyo, Japan), FLAG-tagged TLR7 was cloned from
genomic DNA into pFLAG-CMV1 and FLAG-tagged TLR9 was a gift
from S. Akira (Osaka University, Japan). 24 h after transfection, cells
were washed with phosphate-buffered saline and stimulated with IL-1
(100 ng/ml) (Genzyme Pharmaceuticals, Cambridge, MA), HKLM (105
bacteria/ml), poly(IC) (100 g/ml) (Amersham Biosciences), repurified
LPS (100 ng/ml), phosphothioate-stabilized CpG oligodeoxynucleotides
(10 M, 2006–TCGTCGTTTTGTCGTTTTGTCGTT, gift from K. Heeg,
Institute for Microbiology, Marburg, Germany) or schistosomal adult
worm or egg PS fraction (10 g/ml). Six hours after stimulation, cells
were lysed in reporter lysis buffer (Promega, Madison, WI), and lucif-
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erase activity of the cellular lysate was measured using an assay kit
from Promega (Madison, WI) per the manufacturer’s protocol.
Cell Lines—HEK 293-CD14 and HEK 293-CD14/TLR2 cell lines
were maintained in Dulbecco’s modified Eagle’s medium supplemented
with 10% FCS, 10 g/ml ciprofloxacin, and 5 g/ml puromycin. For
stimulation experiments, cells were seeded at 0.2  106 cells/well in
96-well flat-bottom plates and were stimulated the next day with PS
fractions from schistosomes or hamster liver (5 g/ml). IL-8 production
was measured in supernatants after 20 h using a commercial kit (CLB)
following the manufacturer’s recommendations.
Structural Identification of TLR2-activating Molecules—The schisto-
somal PS preparations were separated by HPLC using a 5-m Lichro-
sphere diol normal-phase column (Merck). Elution was performed at a
flow rate of 1 ml/min by a gradient from 95% eluent A (hexane/isopro-
panol/acetone (82:17:1)) and 5% eluent B (isopropanol/water/acetone
(85:14:1)) to 60% A and 40% B in 30 min, followed by additional elution
with the latter solvent for 10 min. Fractions were collected manually,
evaporated to dryness, and used to stimulate HEK-CD14/TLR2 cells.
Both the total PS preparations and the TLR2-activating HPLC frac-
tion were analyzed using mass spectrometry. Mass spectrometry was
performed on an API-365 triple quad mass spectrometer (Applied Bio-
systems, Nieuwerkerk aan de IJssel, The Netherlands) equipped with
an electrospray ionization source. Negative ionization spectra were
recorded at a scan rate of 200 atomic mass units (amu) per second, using
an ion spray voltage of 4500 V, a declustering potential (cone voltage)
of 30 V, and a focusing potential of 210 V. Alternatively, PS and lyso-PS
were analyzed by recording neutral loss spectra of 87 amu in the
negative ionization mode at ion spray-, decluster-, and focusing poten-
tials mentioned above and with a collision energy of 34 V (r). Nitrogen
was used as collision- and curtain gas and air as the nebulizing gas.
For digestion with phospholipase C, 100 g of the schistosomal adult
worm PS fraction was incubated in 2 ml of diethyl ether and 1 ml of
Tris-HCl buffer (pH 7.2) supplemented with 5 mM CaCl2 and 1.3
units/ml phospholipase C (Sigma) during 3 h while shaking. As a
control, schistosomal PS was incubated in the same buffer in the ab-
sence of phospholipase C. After hydrolysis, the ether was evaporated
and lipids were extracted according to Bligh and Dyer (23).
Statistical Analysis—Data were analyzed for statistical significance
using a paired t test.
RESULTS
PS-activated Dendritic Cells Induce the Development of Po-
larized T Cells—To study whether lipids from helminths are
involved in interaction with the immune system, lipid classes
derived from S. mansoni eggs and adult worms were fraction-
ated on an anion exchange column and were screened for ac-
tivity by their capacity to stimulate cytokine production (IL-6,
IL-8, IL-10, or tumor necrosis factor ) by peripheral blood
mononuclear cells isolated from non-exposed individuals. We
found that the lipid fraction containing PS was an inducer of
cytokine production (data not shown), and we proceeded to
investigate its effects on dendritic cells and subsequent T cell
polarization. So-called dendritic cells type-1 (DC1) have previ-
ously been shown to induce development of Th1 cells, whereas
DC2 cells have been found to promote Th2 development (6).
Human monocyte-derived dendritic cells were exposed to schis-
tosomal PS, schistosomal SEA, a parasite antigen preparation
that has previously been shown to induce DC2 development (6),
and as controls, IFN- (which induces the development of DC1)
or PGE2 (which stimulates the development of DC2) in combi-
nation with neutral maturation factors (MF). After several
washing steps, the fully matured dendritic cells were tested for
cytokine production and used to prime naive T cells. We found
that as reported before (6), upon stimulation with CD40-ligand
(a molecule expressed on T cells that activates dendritic cells),
the IFN- exposed dendritic cells produced high levels of IL-
12p70 (IFN--dendritic cells, 6.2  0.4 ng/ml) compared with
mature control dendritic cells (2.1  0.3 ng/ml) and enhanced
the development of Th1 cells (Fig 1A), whereas PGE2- and
SEA-exposed dendritic cells had suppressed IL-12p70 produc-
tion (PGE2-dendritic cells, 0.3  0.2 ng/ml and SEA-dendritic
cells, 0.3  0.1 ng/ml) and increased frequency of IL-4 produc-
ing T cells (Th2 cells) with decreasing numbers of IFN- pro-
ducing T cells (Fig 1A). The schistosome fraction containing PS
extracted from adult worms or eggs polarized the maturation of
FIG. 1. Polarization of naive T cells by mature dendritic cells.
Human immature monocyte-derived dendritic cells were matured with neu-
tral maturation factors in the presence of IFN-, PGE2, SEA (100 g/ml), or
phosphatidylserine isolated from schistosome eggs or adult worms (10 g/
ml). Subsequently, mature dendritic cells were co-cultured with naive T cells
for 12 days and the T cells were further analyzed. A, T cells restimulated
with PMA and ionomycin were examined for intracellular IL-4 and IFN- by
flow cytometry. One representative of 5 independent experiments is shown.
B, IL-10 production was measured in 24-h supernatants of T cells restimu-
lated with CD3/CD28. Results of 5 independent experiments are shown as
meanS.D., *, p 0.05. C, to assess regulatory capacity, the effect of T cells
grown in the presence of dendritic cells that were matured with MF and
during maturation exposed to medium, IFN-, PGE2, SEA, PS eggs, or PS
worms was determined on the proliferation of autologous Th cells. The result
of 5 independent experiments is shown as mean  S.D., ***, p  0.001.
Similar results were obtained using schistosomal PS in the absence of
neutral maturation factors, although maturation was slightly lower (lower
CD83 expression, data not shown). Because immature dendritic cells have
also been described to affect T cell development (48), experiments performed
in the presence of neutral maturation factors that did not affect T cell
polarization are shown. D, to study the role of IL-10, neutralizing antibodies
were used. The effect of T cells grown in the presence of dendritic cells, which
were matured with MF and during maturation exposed to medium, IFN-,
PGE2 and PS eggs, on proliferation of autologous Th cells was tested in the
presence of a blocking IL-10 antibody or a control antibody. Results of 3
independent experiments are shown.
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dendritic cells, resulting in low IL-12p70 release (PS eggs-
dendritic cells, 0.4  0.2 ng/ml, PS worms-dendritic cells, 0.4 
0.1 ng/ml) and not only in Th2 skewing (Fig 1A) but in contrast
to SEA and PGE2, also in the development of IL-10 producing
T cells (Fig 1B). T cells that develop in co-culture with dendritic
cells, which were matured in the presence of schistosomal PS,
are capable of suppressing proliferation of autologous Th cells
significantly at a Treg:Ttarget cell ratio of 1:1 (Fig 1C). Inhibition
of proliferation was reduced to 50% at a Treg:Ttarget cell ratio of
1:2, and no inhibition was detectable at a 1:4 ratio. The ob-
served suppression of proliferation was abrogated when a
blocking IL-10 antibody was present in the co-culture of regu-
latory T cells (Treg) and target T cells (Fig. 1D), suggesting that
the Treg cells exert their inhibitory function via IL-10.
The low IL-12p70 production was not caused by PS toxicity,
because production of another cytokine (IL-8) by dendritic cells
was unaffected or even enhanced and also no apoptotic cells
were detected as determined using the method described by
Nicoletti et al. (31) (data not shown). Taken together, the mat-
uration of dendritic cells in the presence of schistosome egg- or
adult worm-PS leads to the development of dendritic cells ca-
pable of inducing Treg cells. This is specific for schistosomal PS,
as dendritic cells matured in the presence of SEA or PGE2
(which polarize toward Th2) lacked the capacity to stimulate
the development of the IL-10-producing Treg cells. The mecha-
nism whereby dendritic cells matured in the presence of schis-
tosomal PS induce IL-10-producing T cells is currently being
investigated. Preliminary experiments show that whereas den-
dritic cell-derived soluble factors present in supernatants me-
diate Th2 development, cell-cell contact is required for Treg cell
induction.
Schistosomal PS Activates Toll-like Receptor 2—We tran-
siently transfected HEK 293 cells with human TLR1, TLR2,
TLR3, TLR4MD2, TLR7, and TLR9 to elucidate the mecha-
nism by which schistosomal PS interacts with cells of the
innate immune system. On stimulation with schistosomal PS,
only cells transfected with TLR2 were activated (Fig. 2A).
These results were confirmed by using peritoneal macrophages
of TLR2 / mice, which were unresponsive to schistosomal
PS, whereas macrophages of the control mice showed a clear
response (Fig. 2B). When an anti-TLR2 antibody was added
during dendritic cell maturation in the presence of schistoso-
mal PS, the development of IL-10-producing T cells was dimin-
ished (Fig 3A) whereas Th2 polarization was not affected (Fig.
3B), indicating that TLR2 plays a role in specifically promoting
the development of regulatory T cells, but not Th2 cells.
Structural Characterization of the TLR2-activating PS Mol-
ecule—To confirm that the active molecule present in the schis-
tosomal PS fractions is indeed a phospholipid and not a minor
compound not detectable by mass spectrometry, the schistoso-
mal PS fraction was treated with phospholipase C, which re-
moves the phosphoserine head group from the acylglycerol
moiety, and subsequently HEK CD14/TLR2 stably transfected
cells were stimulated with the resulting lipid fraction. On phos-
pholipase C digestion, the TLR2-stimulating activity was sig-
nificantly reduced (Fig. 4A), indicating that the phosphoserine
head group is required for TLR2 activation. Phosphoserine
alone did not have any TLR2-stimulating activity on HEK
CD14/TLR2 cells (Fig. 4B), demonstrating that both the acyl
group and the phosphoserine moieties of PS form a combined
epitope for activity. In addition, HEK 293 cells stably trans-
FIG. 2. Activation of TLR-2 by schistosome PS. A, HEK 293 cells
were transiently transfected with human TLR1, TLR2, TLR3,
TLR4MD2, TLR7, and TLR9, together with an ELAM-luciferase re-
porter construct and were stimulated with schistosomal PS from eggs
and adult worms (10 g/ml) and HKLM as positive control for TLR-2,
poly(IC) for TLR-3, lipopolysaccharide (LPS) for TLR-4, and CpG DNA
for TLR9. Luciferase activity was determined 6 h after stimulation. B,
peritoneal macrophages from TLR2/mice (n 2) and wild-type mice
(n 2) were stimulated with LPS (taken as 100%), culture medium (),
HKLM, and schistosome PS extracted from eggs and adult worms (10
g/ml), and tumor necrosis factor  production was measured in 24-h
supernatants.
FIG. 3. TLR2 activation on dendritic cells is essential for the
development of IL-10 producing T cells. Dendritic cells were ma-
tured with MF alone () or with MF and PS worms (10 g/ml) in the
presence of a TLR2 blocking antibody or a control antibody. After
maturation, dendritic cells were co-cultured with naive T cells, which
after 12 days were restimulated with immobilized CD3 and soluble
CD28 (A) to measure IL-10 in 24-h supernatants (results of 3 independ-
ent experiments are shown as mean  S.D., **, p  0.01) or PMA and
ionomycin in the presence of brefeldin A (B) and examined for intracel-
lular IL-4 and IFN- (one representative of 3 independent experiments
is shown).
Schistosomal Lysophosphatidylserine Affects Immune Polarization 48125
 at W
A
LA
EU
S LIBRA
RY
 on M
ay 1, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
FIG. 4. Structural analysis of PS preparations. A, PS worms and PS eggs were digested with phospholipase C, and the TLR2 stimulating
activity of the resulting lipids was determined by stimulating HEK 293 CD14/TLR2 transfectants with an amount equivalent to a final
concentration of 10 g/ml undigested material. IL-8 was measured 20 h after stimulation. Results of 3 independent experiments are shown as
mean  S.D., **, p  0.01. B, HEK 293 cells stably transfected with CD14 or CD14 and TLR2, which responded to HKLM but not to LPS, were
stimulated with various concentrations of PS extracted from schistosome eggs, schistosome adult worms or PS isolated from hamster liver,
phosphoserine (without any acyl moieties), and commercially available lyso-PS 16:0. IL-8 production was measured after 20 h. A representative
experiment of 3 independent experiments is shown. PS fractions from schistosome adult worms (C, PS worms), schistosome eggs (D, PS eggs), and
hamster liver (E) were analyzed using tandem MS in the negative mode. Neutral loss scans of 87 amu, corresponding to the loss of serine from the
phospholipid, are given.
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fected with TLR2 responded to schistosomal PS in a dose-de-
pendent manner, but did not respond to any concentration of
PS isolated from the liver of a non-infected mammalian host (a
golden hamster) (Fig. 4B). In agreement with the observation
that mammalian PS did not activate TLR2, it also did not affect
dendritic cell maturation (data not shown).
To identify the structure of the TLR2-activating molecule
within the schistosomal PS preparations, we analyzed the con-
tents of the PS preparations extracted from schistosome adult
worms and eggs and hamster liver using HPLC and tandem
mass spectrometry (Fig. 4, C, D and E, respectively). The PS-
containing fractions comprised a variety of molecules, but they
all showed the typical loss of a serine head group (with a mass
of 87 Da) and showed a great variety in the number of C atoms
and presence of double bonds in the acyl chains. Strikingly,
both in the schistosomal worm and egg PS fractions, PS mole-
cules containing only one acyl chain (so-called lyso-PS mole-
cules) were found, whereas such molecules could not be de-
tected in the hamster liver PS extract (Fig. 4, C–E). Many
different lyso-PS species were detected in the schistosome PS
preparations, with fatty acyl chains containing up to 30 carbon
atoms that were mostly either saturated or monounsaturated.
The worm PS preparation was fractionated by HPLC, and
the fraction containing the TLR2-activating component was
identified by measuring the activation of HEK 293 CD14/TLR2
transfected cells (Fig. 5A). The active fraction (fraction 7) was
analyzed by MS and found to contain lyso-PS molecules,
whereas PS molecules having two acyl chains could not be
detected (Fig. 5B), indicating that TLR2-stimulating activity
resides in the lyso-PS molecules. HPLC fractions 4 and 5 con-
tained PS molecules with 2 acyl chains but no lyso-PS (con-
firmed by MS; data not shown), and did not activate CD14/
TLR2 transfected cells (Fig. 5A). When dendritic cells were
matured in the presence of these HPLC fractions, we found
that Th2 polarization was induced by components in fractions
4 and 5 (Fig. 5C), whereas IL-10-producing T cells primarily
developed in the presence of DC that were matured with frac-
tion 7 (Fig. 5D), indicating that Th2 polarization is induced by
diacylated PS, whereas monoacylated lyso-PS induces develop-
ment of IL-10-producing T cells. Collision-induced dissociation
spectra of the ions found in fraction 7 generated product spec-
tra from which the associated fatty acyl moieties could be
identified as carboxylate ions (data not shown). In this way, the
fatty acids present in lyso-PS from adult schistosomes (molec-
ular ions m/z 550 and m/z 572) were identified as 20:1 and
22:4, respectively (Figs. 4C and 5B), whereas the most abun-
dant lyso-PS species in eggs were 26:1 (m/z 634), 24:0 (m/z 608),
18:0 (m/z 524), 26:2 (m/z 632), and 26:0 (m/z 636) (Fig. 4D). The
differences in lyso-PS species found in schistosome eggs and
adult worms may account for the difference in TLR2-stimulat-
ing activity (Fig. 4B). Because HEK CD14/TLR2 transfectants
failed to respond to commercially available synthetic lyso-PS
16:0, it is clear that the structure of the acyl chain found in
schistosomal lyso-PS is critical for TLR2 reactivity (Fig. 4B). In
agreement with this, lyso-PS 16:0 did not affect polarization of
DC maturation (data not shown).
FIG. 5. Structural identification of TLR2-activating molecules. The schistosome adult worm preparation was fractionated by HPLC and
the resulting fractions were used to stimulate HEK 293 CD14/TLR2 transfectants (A). Fraction 7, which had TLR2-stimulating activity, was
analyzed by MS. Fractions 4 and 5 contained PS molecules with 2 acyl chains (confirmed by MS, data not shown). A negative mode mass spectrum
of fraction 7 is depicted, and the structure of the major component lyso-PS 20:1 (m/z 550.4) is indicated (B). Dendritic cells (0.5 ml) were matured
in the presence of the PS HPLC fractions (derived from 5 g of unfractionated material) and were used to prime the development of naive T cells.
T cell polarization was monitored by intracellular staining of IL-4 and IFN- upon PMA/ionomycin stimulation of T cells (percentage of cytokine
positive T cells grown in the presence of DC matured with neutral MF ( control) was set at 100% (C), and by measurement of IL-10 in 24-h
supernatants of CD3/CD28-stimulated T cells (D).
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DISCUSSION
Dendritic cells form a bridge between innate and adaptive
immunity, acquiring signals from pathogens at the site of in-
fection and subsequently activating naive T cells in the drain-
ing lymph nodes, leading to initiation of a particular immune
response desired either by the host to eliminate the invader, or
by the pathogen to survive. Here we describe a specific inter-
action between parasite-derived lipid structures with not only
the innate but also the adaptive immune system. Schistosomal
phosphatidylserine stimulated innate immune responses in pe-
ripheral blood mononuclear cells of naive individuals and po-
larized maturation of dendritic cells. Polarization of dendritic
cell maturation with schistosomal PS led to the development of
fully mature dendritic cells that were capable of inducing Th2
(Fig. 1A) as well as IL-10-producing (Fig. 1B) regulatory T cells
(Fig. 1, C and D), both features characteristic of immune re-
sponses in chronic schistosome infections. We previously re-
ported that a water-soluble extract of schistosome eggs (SEA)
polarizes DC maturation toward a Th2 phenotype (Fig. 1A) (6).
However, these DC, in contrast to DC matured in the presence
of schistosome PS, do not induce IL-10 producing regulatory T
cells (Fig. 1, B and C).
Use of TLR transfectants as well as gene knockout mice
indicated that schistosome PS (Fig. 2) but not SEA (data not
shown) was able to stimulate TLR2. An important role for
TLR2 in the ability of schistosomal PS to instruct dendritic
cells to induce regulatory T cells was demonstrated by using
blocking antibodies to TLR2 (Fig. 3A). Structural analysis in-
dicated that the number of acyl chains present on schistosomal
PS was critical for its activity. The importance of the acyl
chains for TLR2 activation has been previously reported for
bacterial lipopeptides, in which the removal of two of the three
acyl chains from a synthetic triacyl lipopeptide leads to the loss
of TLR2 activity (17). For schistosomal PS, the opposite is true;
schistosomal PS containing two acyl chains is inactive with
respect to TLR-2 activation, whereas lyso-PS containing only
one acyl chain has prominent TLR-2-activating capacity (Fig.
5). Interestingly, PS (with two acyl chains), when present dur-
ing DC maturation, was able to polarize T cell responses to-
ward Th2- but not toward IL-10-producing T cells, whereas
lyso-PS specifically induced IL-10-producing T cells (Fig. 5).
This is the first report of a TLR2-active monoacylated struc-
ture; reports to date have shown TLR2 activity for triacylated
lipopeptides from bacteria and diacylated lipopeptides from
mycoplasma (15, 26). The fact that lyso-PS 16:0 (16 C lacking a
double bond) failed to activate TLR2-expressing cells indicates
that for TLR2 activation, the presence of a specific acyl chain
structure is required, which is present in schistosomal lyso-PS.
These data suggest a highly specific interaction between a lipid
ligand and a hydrophobic region of TLR2, perhaps residing
within one or more leucine-rich repeats in its extracellular
domain. Because experiments using phospholipase C (Fig. 4A)
suggest that the phosphoserine head group also plays a role in
TLR2 activation, it has to be concluded that both the specific
structure of the acyl group and phosphoserine moiety of lyso-PS
form a combined epitope critical for activity.
Experiments in MyD88/ and Rip2/ mice have indi-
cated that downstream signaling from TLRs is important for
the development of Th1 responses typified by high IFN-, but
not of Th2 responses characterized by IL-4 and IL-5 (32–34).
However, the role of these receptors in induction of immuno-
regulatory responses characterized by high IL-10 or TGF- has
not been analyzed. It is interesting to note that in some exper-
iments performed with human dendritic cells, TLR2 ligands,
which were poor stimulators of IL-12 production, stimulated
IL-10 transcription (14).
It is becoming clear that TLR2 recognizes a wide range of
pathogen-associated molecular patterns with distinct chemical
properties ranging from proteins such as heat shock protein 60
(35), bacterial peptidoglycan (28), or lipids, such as shown here.
The observation that a single TLR can be activated by ligands
that are so diverse may be explained by the ability of the TLRs
to form heterodimers as already shown for TLR2, which can
form dimers with either TLR1 or TLR6 (36, 37). In addition, it
is also clear that although TLRs share common signaling fea-
tures such as IRAK and downstream NF-B activation (38),
they can express relatively unique signaling (39) that may
come from cooperation with other molecules or receptors ex-
pressed in the innate immune system. It remains to be deter-
mined whether additional molecules take part in the recogni-
tion described here. In particular, the recent identification of
several G protein-coupled receptors for lysophospholipids
opens the way for the elucidation of their role in innate immune
responses (18).
Schistosomes do not synthesize fatty acids de novo but rely
on the host for fatty acid supply. However, the parasite has
retained the capability to modify fatty acids by chain elonga-
tion, resulting in a fatty acid profile that is clearly distinct from
that of the host (40–42). For instance, 20:1 and 22:4 are typical
examples of schistosome-specific fatty acids not present in the
mammalian host. We have also shown previously that schisto-
somes display a high rate of deacylation and reacylation, in
contrast to host cells (43). Our current findings indicate that
this high rate of lipid remodeling could specifically target the
immune system via specific receptors actively leading to the
development of regulatory T cells involved in immunosuppres-
sion. Therefore, considering the relationship between exposure
of cells of the innate immune system to PS-bearing apoptotic cells
and induction of an anti-inflammatory state (44), it is tempting to
speculate that the modulating effect of lyso-PS may be a way in
which the parasite exploits the pathways normally used by its
host to prevent excessive inflammation and autoimmune reac-
tions in response to changes in cell membrane lipids.
Strong regulatory responses induced by parasite products
operative during chronic infections may be responsible for bal-
anced host-parasite interaction whereby host tissue damage is
restricted on the one hand and parasite survival is enhanced on
the other (45). Identification of molecular structures capable of
inducing regulatory T cells and elucidation of the mechanisms
by which they do so may contribute to the development of novel
therapeutic strategies with implications beyond parasitology
(46, 47).
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